Jacobs Levy Equity Management
ITCI icon

Jacobs Levy Equity Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Jacobs Levy Equity Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-12,256
Closed -$315K – 1119
2020
Q2 		$315K Hold
12,256
– – ﹤0.01% 879
2020
Q1 		$188K Sell
12,256
-206,159
-94% -$4.48M ﹤0.01% 896
2019
Q4 		$7.49M Buy
218,415
+20,488
+10% +$246K 0.07% 300
2019
Q3 		$1.48M Buy
197,927
+81,243
+70% +$779K 0.02% 563
2019
Q2 		$1.51M Buy
116,684
+7,100
+6% +$91.1K 0.02% 568
2019
Q1 		$1.33M Buy
109,584
+37,570
+52% +$480K 0.02% 600
2018
Q4 		$820K Buy
72,014
+61,389
+578% +$991K 0.01% 641
2018
Q3 		$231K Sell
10,625
-2,295
-18% -$48K ﹤0.01% 910
2018
Q2 		$228K Buy
+12,920
New +$262K ﹤0.01% 933
2018
Q1 		– Sell
-16,770
Closed -$243K – 1073
2017
Q4 		$243K Buy
16,770
+5,100
+44% +$78.7K ﹤0.01% 870
2017
Q3 		$184K Buy
+11,670
New +$171K ﹤0.01% 877
2016
Q2 		– Sell
-53,224
Closed -$1.48M – 1242
2016
Q1 		$1.48M Buy
+53,224
New +$1.77M 0.03% 482

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Jacobs Levy Equity Management's ITCI Position: Q3 2020 in Review

Jacobs Levy Equity Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q3 2020, closing a stake of 12,256 shares — an estimated $315K sold.

Jacobs Levy Equity Management first reported a position in ITCI in Q1 2016 and held it in 12 quarters. The position peaked at $7.49M in Q4 2019. 176 funds tracked by Wall St. Rank hold ITCI as of Q3 2020.

  • Jacobs Levy Equity Management reported no remaining Intra-Cellular Therapies Inc. position as of Q3 2020 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 12,256 Intra-Cellular Therapies Inc. shares in Q3 2020, an estimated $315K.
  • Jacobs Levy Equity Management first reported a position in Intra-Cellular Therapies Inc. in Q1 2016 and held it in 12 quarters.
  • Jacobs Levy Equity Management's Intra-Cellular Therapies Inc. position peaked at $7.49M in Q4 2019.
  • 176 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q3 2020.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2020, filed 16 Nov 2020.